Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies
- 1 January 1993
- journal article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 7 (1) , 11-18
- https://doi.org/10.1002/jcla.1860070104
Abstract
We found that the Rhabdomyosarcoma (RD) cell line expresses human acetylcholine receptor (AChR) based on the following evidences: 1. Soluble AChR can be isolated from RD cells following the isolation procedure for AChR from human muscle; 2. Intact RD cells bind to alpha‐bungarotoxin (αButx) in a time‐dependent and saturable fashion. The apparent dissociation constant (5.3 × 10−10 M) is very similar to that reported for TE671 cells, which is known to express AChR; 3. Like fresh muscle culture, RD cells not only bind but also internalize 125l‐αButx. Soluble AChR from RD cells can be labeled specifically with 125l‐αButx and then used to quantify binding autoantibodies in myasthenic patients. We also demonstrate that blocking antibodies can be detected in sera from patients with myasthenia gravis (MG) using RD cells and the ability of RD cells to internalize αButx. Consequently, RD cells can be used as a reliable source for obtaining soluble AChR and as a replacement for rodent or human muscle cultures in measuring blocking and modulating antibodies.Keywords
This publication has 18 references indexed in Scilit:
- Acetylcholine receptors from normal human muscle: Concentration, purification, and use in radioreceptor assays for autoantibodiesJournal of Clinical Laboratory Analysis, 1991
- Anti‐acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cellsNeurology, 1989
- Cell identity resolvedNature, 1989
- Misidentified cellNature, 1989
- The human medulloblastoma cell line TE671 expresses a muscle‐like acetylcholine receptor Cloning of the α‐subunit cDNAFEBS Letters, 1988
- Neonatal myasthenia gravisNeurology, 1988
- Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia GravisaAnnals of the New York Academy of Sciences, 1987
- Humoral Pathogenesis of Myasthenia GrayisaAnnals of the New York Academy of Sciences, 1987
- Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia GravisNew England Journal of Medicine, 1982
- An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravisClinical Immunology and Immunopathology, 1977